Corcept Therapeutics (CORT) is up 17.7%, or $6.44 to $42.75.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics Phase 3 ROSELLA Trial Achieves Survival Benefit
- Corcept Therapeutics reports ROSELLA trial meets primary endpoint
- Corcept Therapeutics put volume heavy and directionally bearish
- Top 5 Trending Stocks by Unusual Trading Volume, 1/5/26
- Apple, TKO, DigitalBridge, GlobalFoundries, Corcept Trending With Analysts